Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous thoracic paravertebral infusion of methylene blue for postherpetic neuralgia
ChiCTR2000041155Phase 4Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylene blue, vaccinia virus-inoculated rabbit skin extract and ropivacaine in postherpetic neuralgia (PHN) (4 arms), sponsored by Shanghai East Hospital. Primary endpoint: Numerical Rating Scale (NRS) pain score. Started Dec 2020; status: recruiting.
02
Drugs
methylene bluevaccinia virus-inoculated rabbit skin extractropivacaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2000041155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041155.